Ruvise
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Ruvise, covering 2013-01-24 to 2013-04-10. Get the full timeline:
Most recent: EMA Application withdrawn: Ruvise (imatinib) — Novartis Europharm Ltd
2 regulatory and trial events tracked for Ruvise, covering 2013-01-24 to 2013-04-10. Get the full timeline:
Most recent: EMA Application withdrawn: Ruvise (imatinib) — Novartis Europharm Ltd